An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the <i>UBE3A-AS</i> transcriptScott V. Dindot, Jill L. Silverman, Jennifer Panagoulias et al.|Science Translational Medicine|2023Cited by 95
A preclinical pig model of Angelman syndrome mirrors the early developmental trajectory of the human conditionLuke S. Myers, Scott V. Dindot, Sarah Christian et al.|Proceedings of the National Academy of Sciences|2025Cited by 7